IP Library Granted Patent US 9,816,080
Granted Patent B2
US 9,816,080 · App. 14/929,177 · Granted Nov 14, 2017

Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)

Inventors: Quan Lu (Newton, MA); Qiyu Wang (Boston, MA); Stanley N. Cohen (Palo Alto, CA)
Assignees: President and Fellows of Harvard College; The Board of Trustees of the Leland Stanford Junior University
C12N9/16C07K7/06C07K14/4718C12N9/22C12N9/93A61K9/1272C07K2319/00C07K2319/01C07K2319/03C07K2319/70C07K2319/85C12N2810/85
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,816,080
App. No.
14/929,177
Granted
Nov 14, 2017
Kind
B2
Abstract

Methods, systems, compositions and strategies for the delivery of WW domain-containing fusion proteins into cells in vivo, ex vivo, or in vitro via ARMMs are provided. Methods, systems, compositions and strategies for the delivery of Cas9 proteins and/or Cas9 variants into cells in vivo, ex vivo, or in vitro via fusion to ARMM associated proteins (e.g., ARRDC1 or TSG101) are also provided.

Claims (19)

1. An arrestin domain-containing protein 1 (ARRDC1)-mediated microvesicle (ARMM), comprising:

(i) a lipid bilayer and an ARRDC1 protein, and

(ii) a cargo protein, wherein the cargo protein is linked to the ARRDC1 protein via one or more WW domains, and wherein the cargo protein is a Cas9 cargo protein.

2. The microvesicle of claim 1 , comprising an ARRDC1 protein, wherein the ARRDC1 protein comprises any one of the ARRDC1 amino acid sequences set forth in SEQ ID NOs: 15-17.

3. The microvesicle of claim 1 , wherein the Cas9 cargo protein is a nuclease active Cas9 cargo protein.

4. The microvesicle of claim 1 , wherein the Cas9 cargo protein is a nuclease inactive Cas9 (dCas9) cargo protein or a Cas9 nickase cargo protein.

5. The microvesicle of claim 1 , wherein the Cas9 cargo protein comprises an amino acid sequence that is at least 90% identical to a wild-type Cas9 protein.

6. The microvesicle of claim 1 , wherein the Cas9 cargo protein comprises an amino acid sequence that is at least 90% identical to any one of the amino acid sequences selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, and SEQ ID NO: 5.

7. The microvesicle of claim 1 , wherein the Cas9 cargo protein comprises any one of the amino acid sequences selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, and SEQ ID NO: 5.

8. The microvesicle of claim 1 , wherein the Cas9 cargo protein comprises at least one nuclear localization sequence (NLS).

9. The microvesicle of claim 1 , wherein the Cas9 cargo protein is bound to a guide RNA (gRNA).

10. The microvesicle of claim 9 , wherein the guide RNA is a single guide RNA (sgRNA).

11. The microvesicle of claim 1 , wherein the Cas 9 cargo protein is linked to the ARRDC1 protein via two WW domains.

12. The microvesicle of claim 11 , wherein the two WW domains plus the Cas9 cargo protein comprise the amino acid sequence set forth in SEQ ID NO: 65.

13. The microvesicle of claim 1 , wherein the Cas9 cargo protein is linked to the ARRDC1 protein via four WW domains.

14. The microvesicle of claim 13 , wherein the four WW domains plus the Cas9 cargo protein comprise the amino acid sequence set forth in SEQ ID NO: 66.

15. The microvesicle of claim 1 , wherein the ARRDC1 protein comprises a HA tag.

16. The microvesicle of claim 1 , wherein the ARRDC1 protein comprises a GFP.

17. The microvesicle of claim 1 , wherein one or more of the WW domains comprises any one of the amino acid sequences selected from the group consisting of SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, SEQ ID NO: 41, SEQ ID NO: 42, SEQ ID NO: 43, SEQ ID NO: 44, SEQ ID NO: 45, SEQ ID NO: 46, SEQ ID NO: 47, SEQ ID NO: 48, SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 52, SEQ ID NO: 53, SEQ ID NO: 54, SEQ ID NO: 55, SEQ ID NO: 56, SEQ ID NO: 57, SEQ ID NO: 58, SEQ ID NO: 59, SEQ ID NO: 60, SEQ ID NO: 61, SEQ ID NO: 62, SEQ ID NO: 63, and SEQ ID NO: 64.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 17, 2021
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057208/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2016
From: LU, QUAN; WANG, QIYU
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 038007/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2016
From: COHEN, STANLEY N.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 038007/0423 →
Continuity (2)
Provisional Application 62073241 · Oct 31, 2014
Related Publication 20160206566A1 · Jul 21, 2016